CLX insider transactions (Form 4) Open-market purchases and sales. 67 grants, option exercises and tax withholdings are not shown.
Filed
Insider Type
Shares
Price
Value
Since
Score
Nov 5 SEC
Pierre R. Breber ✦ Spy Director Past buys 2/3 beat S&P Buy
4,00022,000 held (+22%)
$100.06
$400K
+6.2%
72
May 5 SEC
Pierre R. Breber ✦ Spy Director Past buys 2/3 beat S&P Buy
5,00018,000 held (+38%)
$85.82
$429K
+23.8%
72
Nov 24 SEC
Pierre R. Breber ✦ Spy Director Past buys 2/3 beat S&P Buy
4,00013,000 held (+44%)
$104.13
$417K
+2.0%
72
Play with CLX in the Research Lab
Pre-set to CLX's latest insider buy of $10K or more (Nov 5, 2026: Pierre R. Breber, $400K). Tap to change anything.
All tools →
Quick backtest: did buys like this beat the market?
Insiders buying Any 1 2 3+
CEO or CFO Any Yes No
Dollar size Any < $250K $250K–1M $1M+
Stock before Any Down 20%+ Down 0–20% Up
Tap a setting to see how 6,290 past insider buys did.
Open the full Backtester →
Research Lab Chart By quarter Setup Odds After the buys Transactions Insiders Earnings Short selling Congress News FAQ
Share price and insider trades
CLX close Insider buy Insider sale
60 80 100 120 140 Dec Jan 2026 Feb Mar Apr May Jun Jul Aug Sep Oct Nov E Earnings release filed 2026-02-03 E Earnings release filed 2026-04-30 E Earnings release filed 2026-08-03 E Earnings release filed 2026-11-02 Bought $400,251 on 2026-11-04 · Pierre R. Breber Bought $416,516 on 2025-11-21 · Pierre R. Breber Bought $429,124 on 2026-05-05 · Pierre R. Breber
Bought, 12 months $1.2M
Sold, 12 months $0
Insiders buying 1
Insiders selling 0
Clorox insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $1.2M and 0 sold $0 of CLX stock on the open market; P/E 19.1 vs. a sector median of 21.2.
Setup Odds: how past setups like this did CLX's latest insider buying (Nov 5, 2026) matched against every similar buy since 2020.
How it works →
1 insider buying no CEO or CFO $250K–$1M stock down 0–20% in 3 months
111 of 221 past setups like this beat the S&P 500 over the next 90 days (50%) , against 46% for all insider buys.
Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500 Did not beat the S&P 500
50 of 100 similar setups beat the S&P 500 beat didn't
−40% −20% 0% = S&P +20% +40%
How those 221 cases did vs. the S&P 500 over 90 days. Hover a bar for counts.
Outcome Cloud each dot is one of these 221 past setups; the white ring is CLX's buy, result due in 90 days
Beat the S&P 500 ↑ Lagged ↓ -50% -25% +0% +25% +50% 2020 2021 2022 2023 2024 2025 2026 BDC 2022-06-21: +31% vs S&P +4% BHVN 2026-03-09: +6% vs S&P +9% ASPN 2023-09-07: +84% vs S&P +3% ADSK 2025-03-24: +10% vs S&P +4% BSM 2026-05-14: +7% vs S&P +4% ASMB 2024-01-19: +29% vs S&P +4% ADP 2026-05-11: +29% vs S&P +5% COLD 2020-12-10: +3% vs S&P +7% OPBK 2022-12-15: -19% vs S&P +0% WY 2022-06-09: -10% vs S&P -0% ACRE 2022-02-25: +5% vs S&P -7% CROX 2024-10-30: -5% vs S&P +5% BMRN 2022-11-02: +37% vs S&P +9% ARKR 2022-12-22: +9% vs S&P +3% ACGL 2026-05-04: +7% vs S&P +4% BRK-B 2026-05-06: +10% vs S&P +5% CODI 2020-06-04: +5% vs S&P +15% CLAR 2024-11-14: +11% vs S&P +2% MBC 2024-08-13: +17% vs S&P +11% BXP 2020-03-12: -10% vs S&P +29% BBW 2022-03-21: +1% vs S&P -17% BXP 2023-03-15: +2% vs S&P +13% TREIX 2023-01-05: +2% vs S&P +8% ADBE 2022-01-10: -15% vs S&P -4% ALLE 2025-11-25: -4% vs S&P +1% COLB 2021-11-29: +13% vs S&P -5% AASP 2026-04-29: +40% vs S&P +4% CE 2022-02-28: +15% vs S&P -5% CME 2024-01-19: +4% vs S&P +4% CME 2020-06-12: -6% vs S&P +10% MBUU 2024-02-23: -16% vs S&P +4% AUR 2025-08-07: -28% vs S&P +7% BX 2022-04-28: -9% vs S&P -6% CDW 2023-05-04: +21% vs S&P +12% BANF 2021-09-14: +23% vs S&P +5% CAI 2026-07-13: +74% vs S&P +4% AFG 2025-02-24: +3% vs S&P -3% CLMT 2023-11-21: +10% vs S&P +11% ATRA 2021-06-15: +15% vs S&P +6% OPBK 2022-08-31: -3% vs S&P +0% AJG 2025-11-03: +3% vs S&P +2% BRO 2023-03-17: +23% vs S&P +13% ALLE 2026-03-12: -11% vs S&P +9% ONEW 2026-02-13: -6% vs S&P +10% BUR 2025-03-10: +4% vs S&P +7% ALKS 2022-11-16: +24% vs S&P +5% CBSH 2022-06-13: +9% vs S&P +9% BHM 2023-03-14: -16% vs S&P +11% CLFD 2025-12-15: -2% vs S&P -2% AGCO 2025-05-07: +21% vs S&P +12% BETA 2026-05-21: +65% vs S&P +4% CDZI 2026-05-28: -8% vs S&P +2% CFR 2022-05-04: -5% vs S&P -4% AESI 2024-10-28: +21% vs S&P +5% OPBK 2022-03-08: -6% vs S&P -1% BPRN 2024-03-18: +3% vs S&P +6% CAG 2021-01-11: +10% vs S&P +9% AMD 2025-02-12: +1% vs S&P -2% COST 2022-06-08: +11% vs S&P -5% DAL 2024-07-15: +20% vs S&P +4% BSTZ 2021-03-23: +18% vs S&P +8% ALTO 2021-05-20: -18% vs S&P +6% AUB 2024-06-10: +22% vs S&P +1% TBLD 2022-01-05: -7% vs S&P -3% CLX 2025-11-24: +18% vs S&P +3% CMG 2021-04-27: +23% vs S&P +6% CRC 2021-12-22: +8% vs S&P -4% ALSN 2025-08-25: -4% vs S&P +3% AMG 2023-03-17: +13% vs S&P +13% C 2020-10-16: +62% vs S&P +9% RBB 2024-03-18: +2% vs S&P +6% AXP 2025-03-11: +18% vs S&P +8% MRNA 2020-02-18: +323% vs S&P -12% CCOI 2022-11-15: +19% vs S&P +4% CVS 2020-05-13: +8% vs S&P +19% AAP 2023-09-14: +3% vs S&P +5% AMSF 2021-08-26: +7% vs S&P +6% BA 2026-05-22: -2% vs S&P +3% CRM 2025-09-10: +8% vs S&P +5% CNNE 2020-03-13: +16% vs S&P +12% AAON 2025-12-15: +9% vs S&P -2% CODI 2022-05-16: +9% vs S&P +7% BSM 2024-08-15: +7% vs S&P +8% BAC 2023-11-03: +19% vs S&P +13% WWD 2021-08-04: +6% vs S&P +6% BTT 2022-01-25: -9% vs S&P -1% CMCL 2026-08-17: -10% vs S&P -2% CKX 2022-09-06: -3% vs S&P +3% AUNA 2026-06-01: +14% vs S&P +2% BPRN 2025-02-12: +6% vs S&P -2% AMH 2022-11-23: +3% vs S&P -0% AUBN 2020-03-12: +34% vs S&P +29% ARCC 2023-05-04: +13% vs S&P +12% GBLI 2021-11-16: +0% vs S&P -6% CRMD 2025-10-27: -34% vs S&P +1% COP 2025-06-17: -3% vs S&P +11% CBSH 2022-07-28: -0% vs S&P -6% AMT 2026-03-12: +8% vs S&P +9% RBB 2022-05-02: +6% vs S&P -0% BKGM 2020-03-09: -10% vs S&P +17% AESI 2025-02-28: -35% vs S&P -0% BWB 2020-09-03: +21% vs S&P +7% BRK-A 2022-07-07: +0% vs S&P -3% ASMB 2024-11-26: -17% vs S&P -0% ARDX 2025-02-26: -22% vs S&P -0% ATR 2022-11-03: +24% vs S&P +11% BG 2026-08-04: -11% vs S&P -2% AN 2022-05-23: +17% vs S&P +7% CHD 2021-03-04: +10% vs S&P +12% BL 2025-08-11: +12% vs S&P +6% CNO 2023-05-19: +7% vs S&P +5% APO 2022-08-31: +19% vs S&P +0% ADI 2022-06-21: +1% vs S&P +4% AMD 2025-05-22: +49% vs S&P +10% AZO 2022-03-21: +3% vs S&P -17% AMT 2025-11-04: -3% vs S&P +3% CRM 2025-03-03: -9% vs S&P +1% CLVT 2025-08-05: -4% vs S&P +9% AYI 2026-04-10: +20% vs S&P +11% ASYS 2022-05-17: +13% vs S&P +5% AIR 2021-07-29: -6% vs S&P +3% BST 2022-02-04: -14% vs S&P -7% BCAT 2021-11-24: -12% vs S&P -8% OPBK 2022-11-08: +6% vs S&P +8% CWH 2022-05-19: +22% vs S&P +10% BUSE 2025-03-12: +8% vs S&P +8% ASPI 2024-07-10: -19% vs S&P +2% BRCC 2025-08-11: -15% vs S&P +6% CLVT 2021-06-15: -5% vs S&P +6% CRSR 2021-04-09: -7% vs S&P +5% CLX 2025-05-09: -6% vs S&P +12% ACNB 2021-07-01: -2% vs S&P +1% BAH 2024-11-25: -23% vs S&P +1% ARKR 2022-06-28: +2% vs S&P -4% AHCO 2021-03-18: -24% vs S&P +8% CME 2022-12-05: +6% vs S&P +2% CLNN 2022-03-30: -24% vs S&P -17% CCI 2020-12-14: +3% vs S&P +9% LEU 2023-03-17: +7% vs S&P +13% CMI 2025-05-16: +22% vs S&P +9% BHR 2022-05-18: +1% vs S&P +10% BRCC 2025-11-19: -43% vs S&P +3% MEGI 2025-01-06: +3% vs S&P -15% ARDX 2025-01-22: -5% vs S&P -13% CRK 2022-08-08: +24% vs S&P -8% BH 2026-06-05: +31% vs S&P +5% XMTR 2024-05-31: +32% vs S&P +6% CMTG 2022-08-18: -1% vs S&P -7% BHVN 2023-08-31: +76% vs S&P +1% DAL 2023-04-27: +40% vs S&P +11% AOSL 2026-03-10: +120% vs S&P +9% CRT 2026-06-26: +38% vs S&P +6% GBCI 2021-07-29: +3% vs S&P +3% COP 2025-11-10: +23% vs S&P +2% BKNG 2022-08-09: -6% vs S&P -7% ASTC 2022-09-07: -23% vs S&P -1% ASPU 2021-10-04: -59% vs S&P +11% CMG 2022-05-20: +32% vs S&P +10% AGO 2022-08-09: +12% vs S&P -7% JKHY 2023-05-30: +7% vs S&P +6% BSTZ 2025-03-14: +9% vs S&P +8% CTOS 2023-05-16: +3% vs S&P +10% BALL 2022-12-07: +5% vs S&P +2% AAACX 2020-07-28: -1% vs S&P +6% CORT 2020-09-01: +81% vs S&P +3% BV 2026-08-06: +10% vs S&P +0% AEYE 2025-11-24: -42% vs S&P +3% ADC 2026-06-08: +0% vs S&P +4% ADBE 2025-01-30: -16% vs S&P -8% ALIT 2021-12-10: -13% vs S&P -9% ADSK 2026-05-29: +17% vs S&P +2% BRC 2022-03-16: +2% vs S&P -14% DAL 2021-12-01: +12% vs S&P -4% AGEN 2024-02-15: -17% vs S&P +6% ALIT 2025-05-20: -31% vs S&P +9% ARDX 2024-11-14: +16% vs S&P +2% ALIT 2022-03-15: -20% vs S&P -12% AWK 2023-11-06: -3% vs S&P +14% ADC 2025-06-13: -0% vs S&P +10% CMTV 2024-08-05: +7% vs S&P +11% OSG 2020-07-13: +1% vs S&P +11% FBK 2023-06-09: -3% vs S&P +4% CCI 2022-02-24: +16% vs S&P -7% ARTV 2026-07-31: -58% vs S&P +3% CBNA 2025-03-03: +12% vs S&P +1% FBK 2025-02-14: -11% vs S&P -3% APTV 2025-12-16: -8% vs S&P -1% CBOE 2020-11-05: +15% vs S&P +9% BAX 2020-04-01: +10% vs S&P +26% ONEW 2023-02-23: -3% vs S&P +3% CSX 2022-05-16: +4% vs S&P +7% ACR 2023-01-04: +8% vs S&P +7% THG 2021-11-30: +15% vs S&P -4% AMG 2026-05-06: +25% vs S&P +5% AXR 2023-10-13: +31% vs S&P +11% BX 2022-03-01: -1% vs S&P -3% AMPY 2023-03-15: +1% vs S&P +13% AES 2021-09-16: -0% vs S&P +6% CFR 2020-02-10: -25% vs S&P -12% BWFG 2023-03-23: -0% vs S&P +11% BOTJ 2021-08-23: +14% vs S&P +5% CARG 2026-03-04: -15% vs S&P +11% BDX 2025-02-10: -27% vs S&P -6% LMND 2026-03-30: +0% vs S&P +16% CRSP 2025-02-28: -16% vs S&P -0% LMNR 2021-09-28: +4% vs S&P +10% BRCC 2023-12-12: +15% vs S&P +11% AGL 2026-03-03: +553% vs S&P +12% BMBL 2022-03-18: +2% vs S&P -18% BX 2022-05-25: -7% vs S&P +4% ACR 2022-09-06: +1% vs S&P +3% BWFG 2022-06-28: -5% vs S&P -4% ARDC 2022-01-27: -8% vs S&P -3% MED 2021-11-10: -11% vs S&P -2% CAG 2023-10-10: +6% vs S&P +10% CAG 2021-07-16: -2% vs S&P +3% CRL 2023-02-24: -11% vs S&P +5% MEGI 2024-03-20: +2% vs S&P +5% C 2020-09-04: +9% vs S&P +7% AOS 2022-02-22: -16% vs S&P -7% BCO 2022-06-14: +1% vs S&P +10% This buy: result due Feb 3, 2027
Median vs. S&P 500 +0.0%
Average vs. S&P 500 +5.4%
Best +552.8%
Worst -59.3%
History, not a prediction: what happened next in similar past cases, measured from the day the last filing became public. Not investment advice.
By InsiderPrint Research Desk · Updated Nov 20, 2026 · Sources: SEC EDGAR Form 4 filings , FINRA short-sale volume · How we calculate this
CLX insider buying and selling by quarter Open-market purchases (green, above the line) and sales (red, below), by trade date.
Q4 2025: $417K bought (1 trades) $417K Q4 2025 Q1 2026 Q2 2026: $429K bought (1 trades) $429K Q2 2026 Q3 2026 Q4 2026: $400K bought (1 trades) $400K Q4 2026
Quarter Bought Purchases Sold Sales
Q4 2026 $400K 1 — 0 Q3 2026 — 0 — 0 Q2 2026 $429K 1 — 0 Q1 2026 — 0 — 0 Q4 2025 $417K 1 — 0
P/E (trailing) 19.1 Sector median 21.2
Market value $12.87B Household & Personal Products
Profit margin 9.4% Revenue growth +33.3%
Volume vs. 50-day 0.8× Last 5 sessions
Insiders' paper profit +$135K On all tracked purchases +10.8%
Source: Yahoo Finance, as of Nov 20, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 Clorox insider reported open-market purchases totaling $1.2M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Pierre R. Breber (Director) has the highest Insider Score at 72.
CLX earnings: how the stock reacted Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
Does it matter? →
Release 15 days before Insiders, 30 days before Reaction (2 days) Next 30 days
Nov 2, 2026
+3.6%
None
+6.6% S&P -0.2%
pending
Aug 3, 2026
-3.2%
None
+9.6% S&P +3.3%
-8.9%
Apr 30, 2026
-8.1%
None
-8.1% S&P +1.3%
+3.3%
Feb 3, 2026
+4.2%
None
+4.0% S&P -1.3%
-2.6%
Nov 3, 2025
-3.4%
None
-1.8% S&P -1.0%
-4.8%
Jul 31, 2025
+1.6%
None
-2.4% S&P -2.0%
-3.0%
May 5, 2025
+0.4%
None
-2.9% S&P -1.4%
-5.7%
Feb 3, 2025
-0.4%
None
-6.6% S&P -0.0%
+0.1%
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
CLX short selling Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
20% 40% 60% 2026-08-26: 77% of volume sold short 2026-08-27: 66% of volume sold short 2026-08-28: 73% of volume sold short 2026-08-31: 65% of volume sold short 2026-09-01: 64% of volume sold short 2026-09-02: 58% of volume sold short 2026-09-03: 53% of volume sold short 2026-09-04: 49% of volume sold short 2026-09-08: 66% of volume sold short 2026-09-09: 69% of volume sold short 2026-09-10: 69% of volume sold short 2026-09-11: 65% of volume sold short 2026-09-14: 65% of volume sold short 2026-09-15: 74% of volume sold short 2026-09-16: 75% of volume sold short 2026-09-17: 65% of volume sold short 2026-09-18: 51% of volume sold short 2026-09-21: 68% of volume sold short 2026-09-22: 59% of volume sold short 2026-09-23: 68% of volume sold short 2026-09-24: 65% of volume sold short 2026-09-25: 68% of volume sold short 2026-09-28: 62% of volume sold short 2026-09-29: 62% of volume sold short 2026-09-30: 64% of volume sold short 2026-10-01: 61% of volume sold short 2026-10-02: 61% of volume sold short 2026-10-05: 66% of volume sold short 2026-10-06: 66% of volume sold short 2026-10-07: 71% of volume sold short 2026-10-08: 55% of volume sold short 2026-10-09: 63% of volume sold short 2026-10-12: 66% of volume sold short 2026-10-13: 67% of volume sold short 2026-10-14: 69% of volume sold short 2026-10-15: 51% of volume sold short 2026-10-16: 70% of volume sold short 2026-10-19: 71% of volume sold short 2026-10-20: 57% of volume sold short 2026-10-21: 63% of volume sold short 2026-10-22: 54% of volume sold short 2026-10-23: 63% of volume sold short 2026-10-26: 59% of volume sold short 2026-10-27: 67% of volume sold short 2026-10-28: 49% of volume sold short 2026-10-29: 63% of volume sold short 2026-10-30: 56% of volume sold short 2026-11-02: 54% of volume sold short 2026-11-03: 64% of volume sold short 2026-11-04: 45% of volume sold short 2026-11-05: 47% of volume sold short 2026-11-06: 54% of volume sold short 2026-11-09: 62% of volume sold short 2026-11-10: 52% of volume sold short 2026-11-11: 49% of volume sold short 2026-11-12: 65% of volume sold short 2026-11-13: 62% of volume sold short 2026-11-16: 59% of volume sold short 2026-11-17: 49% of volume sold short 2026-11-18: 43% of volume sold short Aug 26 Sep 10 Sep 24 Oct 8 Oct 22 Nov 5
Latest (Nov 18): 43% 20-day average: 55% Prior 2 months: 64%
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded CLX From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
All Congress trades →
Member Trade Traded Reported Since trade
Gilbert Ray Cisneros, Jr. House · D-CA
Sold $1,001 - $15,000
May 15, 2026 Jun 8, 2026
+18.8%
Gilbert Ray Cisneros, Jr. House · D-CA
Bought $1,001 - $15,000
Dec 19, 2025 Jan 12, 2026
+11.9%
Gilbert Ray Cisneros, Jr. House · D-CA
Sold $1,001 - $15,000
Nov 12, 2025 Dec 15, 2025
+5.1%
Lisa C. McClain House · R-MI
Sold $1,001 - $15,000
Oct 31, 2025 Nov 21, 2025
-2.2%
Lisa C. McClain House · R-MI
Sold $1,001 - $15,000
Oct 30, 2025 Nov 21, 2025
-2.2%
Lisa C. McClain House · R-MI
Bought $1,001 - $15,000
Oct 30, 2025 Nov 21, 2025
-2.2%
CLX stock news and SEC filings Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
What happened after CLX insiders bought Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
Across all stocks →
Filed Insider Bought 7 days 30 days 90 days
Nov 5, 2026 Pierre R. Breber Director $400K
+8.5% +5.2% vs S&P pending pending May 5, 2026 Pierre R. Breber Director $429K
+3.5% +1.5% vs S&P +4.1% -0.5% vs S&P +14.1% +9.1% vs S&P Nov 24, 2025 Pierre R. Breber Director $417K
+0.7% -1.0% vs S&P -7.1% -10.6% vs S&P +21.3% +19.0% vs S&P
Insiders at Clorox
Insider Bought Sold Last filing Past buys beat S&P Score
Pierre R. Breber Director
$1.2M
—
Nov 5, 2026
2 of 3
72
Linda J. Rendle CEO
—
—
Oct 7, 2026
—
—
Angela C. Hilt General Counsel
—
—
Oct 7, 2026
—
—
Kirsten Marriner Evp - Chief Admin Officer
—
—
Oct 7, 2026
—
—
Chris T. Hyder COO
—
—
Oct 7, 2026
—
—
Luc Bellet CFO
—
—
Oct 7, 2026
—
—
Laurene E. Peck Vp - Cao & Corp Controller
—
—
Oct 7, 2026
—
—
Nina Barton Evp-Chief Growth & Strategy Of
—
—
Oct 7, 2026
—
—
Stacey Grier Evp - Executive Chief Of Staff
—
—
Mar 17, 2026
—
—
Eric H. Reynolds COO
—
—
Dec 16, 2025
—
—
Board links: companies that share insiders with CLX Directors and executives who filed Form 4s for CLX and another company in the last 12 months.
See the map →
LUV Southwest Airlines
Pierre R. Breber Director here · Director at LUV · latest filing Nov 5, 2026
Insider activity at other Consumer Staples companies Same sector, ranked by insider buying in the last 90 days.
COUR Coursera, Inc. $42.8M bought LRN Stride, Inc. $39.6M bought COE 51Talk Online Education Group $32.3M bought PEP PepsiCo $23.7M bought DOLE Dole plc $21.6M bought SUJA SUJA LIFE, INC. $20.3M bought
CLX stock: common questions
Are Clorox insiders buying CLX stock? In the past 12 months, 1 insider reported open-market purchases of CLX worth $1.2M. The latest was Director Pierre R Breber bought $400K of CLX at $100.06 — raises the stake by 22%.
Are Clorox insiders selling CLX stock? No. No Clorox insider reported an open-market sale of CLX in the past 12 months.
Where does this data come from? Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CLX's P/E ratio? CLX trades at about 19.1 times trailing earnings, compared with a median of 21.2 for the Consumer Staples sector.
What is CLX's 52-week range? Over the past year CLX has traded between $79.26 and $124.13. It last closed at $106.23 on Nov 20, 2026.